ClinConnect ClinConnect Logo
Search / Trial NCT06116747

The SUPPORTED Study - First-time Fathers of Preterm Infants.

Launched by HVIDOVRE UNIVERSITY HOSPITAL · Oct 31, 2023

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Preterm Father Child Relations

ClinConnect Summary

Project description The overall aim of this research study is to identify, develop and evaluate whether supportive strategies for first-time fathers (FTF) of preterm infants will improve parental confidence, mood and anxiety as well as increasing paternal reflective function, and improve infants social-emotional competencies during admission in the Neonatal Intensive Care Unit (NICU), or Maternity Unit (MU) and follow up at home by health visitors in the municipalities in all five regions in Denmark. Thus, improve paternal confidence in the father role by involving, knowledge sharing, and g...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • First-time fathers of preterm infants
  • Co-habitating with the mother of the infant
  • Neonatal Admission for more than seven days
  • Danish language
  • Infants born before the 37 week of gestation
  • Exclusion Criteria:
  • Infant receiving palliative treatment and care
  • parents not discharged for home
  • parental mental illness

About Hvidovre University Hospital

Hvidovre University Hospital is a leading clinical research institution located in Denmark, dedicated to advancing medical science through rigorous clinical trials and innovative healthcare solutions. As a prominent academic hospital, it integrates patient care with research, fostering collaboration among multidisciplinary teams of healthcare professionals, researchers, and academic institutions. Hvidovre University Hospital is committed to enhancing patient outcomes by conducting high-quality clinical studies across various therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. Its state-of-the-art facilities and focus on translational medicine position the hospital as a key player in the development of new treatments and therapies, ultimately contributing to the improvement of public health.

Locations

Hvidovre, , Denmark

Patients applied

0 patients applied

Trial Officials

Anne Brødsgaard

Principal Investigator

Hvidovre University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported